-
Loading metrics
Open Access
Peer-reviewed
Research Article
L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro
-
Hongbiao Huang ,
Contributed equally to this work with: Hongbiao Huang, Ningning Liu, Haiping Guo
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Ningning Liu ,
Contributed equally to this work with: Hongbiao Huang, Ningning Liu, Haiping Guo
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Haiping Guo ,
Contributed equally to this work with: Hongbiao Huang, Ningning Liu, Haiping Guo
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Siyan Liao,
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Xiaofen Li,
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Changshan Yang,
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Shouting Liu,
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Wenbin Song,
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Chunjiao Liu,
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Lixia Guan,
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Bing Li,
Affiliation Experimental Medical Research Center, Guangzhou Medical College, Guangzhou, Guangdong, People's Republic of China
⨯ -
Li Xu,
Affiliations Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China, Department of Hematology, The People's Hospital of Guangxi Autonomous Region, Nanning, Guangxi, People's Republic of China
⨯ -
Change Zhang,
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ -
Xuejun Wang,
Affiliation Division of Basic Biomedical Sciences, Sanford School of Medicine of the University of South Dakota, Vermillion, South Dakota, United States of America
⨯ -
Q. Ping Dou ,
* E-mail: Liujinbao1@yahoo.com.cn (JL); doup@karmanos.org (QPD)
Affiliations Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China, The Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, and Departments of Oncology, Pharmacology and Pathology, School of Medicine, Wayne State University, Detroit, Michigan, United States of America
⨯ - [ ... ],
-
Jinbao Liu
* E-mail: Liujinbao1@yahoo.com.cn (JL); doup@karmanos.org (QPD)
Affiliation Protein Modification and Degradation Lab, Department of Pathophysiology, Guangzhou Medical College, Guangdong, People's Republic of China
⨯ - [ view all ]
- [ view less ]
L-Carnitine Is an Endogenous HDAC Inhibitor Selectively Inhibiting Cancer Cell Growth In Vivo and In Vitro
- Hongbiao Huang,
- Ningning Liu,
- Haiping Guo,
- Siyan Liao,
- Xiaofen Li,
- Changshan Yang,
- Shouting Liu,
- Wenbin Song,
- Chunjiao Liu,
- Lixia Guan
- Published: November 5, 2012
- https://doi.org/10.1371/journal.pone.0049062